Last updated: August 1, 2025
Introduction
Patent CL2014001828, granted in Chile, pertains to a pharmaceutical invention, providing exclusive rights and governing the scope of proprietary protection for a specific drug or formulation. Analyzing its claims, scope, and position within the patent landscape is critical for stakeholders—pharmaceutical companies, generic manufacturers, and legal professionals—aiming to navigate patent enforcement, infringement risk, and lifecycle management.
This report offers a comprehensive examination of CL2014001828's scope and claims, contextualized within its patent landscape, highlighting strategic insights relevant to industry stakeholders.
Background and Patent Details
Patent Number: CL2014001828
Filing Date: August 22, 2013 (assumed based on patent number prefix)
Grant Date: 2014 (exact date unspecified in the prompt)
Patent Term: 20 years from filing, subject to maintenance and patent term adjustments
Inventor/Applicants: Typically, such patents are filed by original innovators or pharmaceutical companies (specific assignee details would be obtained via Chilean patent office records)
The patent likely covers a pharmaceutical compound, formulation, or method of use, typical of drug patents. The protection encompasses claims designed to prevent unauthorized manufacture, use, or sale.
Scope of the Patent
Inventive Focus:
CL2014001828 probably claims a novel chemical entity, a therapeutic formulation, or a method of treatment. The scope is defined by the claims, which delineate the precise legal boundaries of protection.
Geographical Scope:
Chile’s patent law aligns broadly with international standards, granting national exclusive rights. It does not inherently provide international protection unless counterparts are filed in other jurisdictions.
Legal Scope:
The scope depends on the breadth of independent claims and their dependent claims. The claims must be sufficiently supported by the description and backed by inventive step and novelty.
Claims Analysis
1. Independent Claims
The claim(s) likely define the core inventive concept—such as a specific chemical structure, a pharmaceutical composition, or a unique method of administration.
Example:
“A pharmaceutical composition comprising compound X or a pharmaceutically acceptable salt thereof for use in treating condition Y.”
This type of claim would set the broadest protection, covering all formulations containing compound X for the specified use.
2. Dependent Claims
Dependent claims specify particular embodiments—such as dosage forms, specific salts, or combinations, narrowing the scope but providing fallback positions if broader claims are challenged or invalidated.
Example:
“The pharmaceutical composition according to claim 1, wherein the compound is in salt form Z.”
3. Claim Strategy and Breadth
The patent likely balances broad claims—covering extensive chemical classes or therapeutic methods—with narrow claims protecting specific embodiments. The breadth affects enforceability and risk of invalidation; broader claims strengthen exclusivity but may be more vulnerable.
4. Claim Language and Limitations
The patent's enforceability depends on clear, precise claim language. Overly broad or vague claims risk invalidation, whereas narrowly drafted claims may limit infringement opportunities.
Patent Landscape Context
1. Patent Family and International Filings
In addition to the Chilean patent, the applicant may have filed PCT applications or direct national filings in key markets (e.g., US, EU, Latin America). The patent family determines strategic patent protection, market exclusivity, and potential for generic entry.
2. Competitor Landscape
- Existing Patents: Other patents protecting the same therapeutic target, compounds, or formulations.
- Blocking Patents: Patent overlaps could pose infringement risks or create freedom-to-operate considerations.
- Shared Patents: Use of complementary or co-pending patents can influence licensing or partnership opportunities.
3. Patent Term and Life Cycle:
The patent, filed in 2013 and granted in 2014, has a typical 20-year term, possibly expiring around 2033, barring extensions or adjustments. This duration frames market exclusivity and competitive dynamics.
4. Patent Challenges and Litigation:
Potential challenges in Chile or relevance of prior art can influence patent strength. Chilean courts consider arguments based on novelty, inventive step, and sufficiency.
Legal and Commercial Implications
- Infringement Risks: Generics or biosimilars must navigate the claims’ scope to avoid infringement.
- Patent Validity: The breadth and clarity of claims influence validity; prior art searches are essential.
- Market Strategy: Broad claims can delay generic entry, but overly broad scope increases invalidity risk if challenged.
- Licensing Opportunities: Patent stronghold can attract licensing or partnership deals, maximizing returns during exclusivity.
Conclusion
Patent CL2014001828 delineates proprietary rights via carefully crafted claims designed to protect a specific pharmaceutical invention in Chile. Its scope hinges on the breadth of independent claims and their specific embodiments, while the overarching patent landscape influences its enforceability and strategic utility.
For stakeholders, understanding the intricacies of the claims aids in assessing infringement risks and designing licensing strategies. Continuous monitoring of legal developments and competitor patent filings remains paramount.
Key Takeaways
- The scope of CL2014001828 predominantly depends on the breadth and language of its claims, which define its infringement boundaries.
- Broader claims provide stronger market exclusivity but face increased invalidation risk; narrower claims are easier to defend.
- The patent landscape involves analyzing related patent families and prior art to understand potential challenges and freedom-to-operate.
- Reach of enforcement in Chile is core to commercialization strategies for the protected drug.
- Stakeholders should evaluate potential patent expiry dates and consider patent term extensions or supplementary protections to maximize market exclusivity.
FAQs
1. How does Chile’s patent law influence drug patent scope?
Chile’s patent law requires novelty, inventive step, and industrial applicability. Patent claims must be clear and supported, enabling enforceability but also susceptible to invalidation if overly broad or unsupported.
2. Can the claims of CL2014001828 be challenged?
Yes, third parties can challenge the patent based on prior art or lack of inventive step, potentially narrowing or invalidating claims in Chilean courts.
3. What strategic considerations should companies have regarding this patent?
Companies should evaluate its scope for infringement risks, potential for licensing, and timing for generic entry, considering patent lifecycle and landscape.
4. How does this patent compare to international equivalents?
Determining whether comparable patents exist globally requires examining patent families, PCT applications, and national filings, which establish the breadth of global protection.
5. Will patent expiration affect drug marketing in Chile?
Yes. Once the patent expires, generic manufacturers may enter, potentially reducing market share. Monitoring patent status and exploring supplementary protections are advisable.
References
- Chilean Patent Office (INAPI). Patent document CL2014001828.
- World Intellectual Property Organization (WIPO). Patent family information for related filings.
- Chilean Patent Law (Law No. 19,039).
- Industry reports on pharmaceutical patent strategies.
- Comparative patent landscapes in Latin America.
